A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features

被引：3

作者：

Pinsolle, Julian ^{[1
,2
]}

Mondet, Julie ^{[2
,3
,4
]}

Duruisseaux, Michael ^{[1
]}

DAlnoncourt, Segolene ^{[2
,4
]}

Magnat, Nelly ^{[3
]}

de Fraipont, Florence ^{[3
,5
,6
]}

Moro-Sibilot, Denis ^{[1
,2
,5
]}

Toffart, Anne-Claire ^{[1
,2
,5
]}

Brambilla, Elisabeth ^{[2
,5
]}

McLeer-Florin, Anne ^{[2
,3
,4
,5
]}

机构：

[1] Clin Hosp Univ Pneumol Physiol, Pole Thorax & Vaisseaux, CHU Grenoble Alpes, Grenoble, France

[2] Univ Grenoble Alpes, Grenoble, France

[3] CHU Grenoble Alpes, Plateforme Genet Mol Canc, Grenoble, France

[4] CHU Grenoble Alpes, Dept Anat & Cytol Pathol, Pole Biol & Pathol, Grenoble, France

[5] Univ Grenoble Alpes, Inst Adv Biosci, UGA INSERM U1209 CNRS 5309, Grenoble, France

[6] CHU Grenoble Alpes, Pole Biol & Pathol, Serv Biochim Biol Mol & Toxicol Environm, Grenoble, France

来源：

CLINICAL LUNG CANCER | 2019年 / 20卷 / 05期

关键词：

ALK rearrangement; CLIP1; Fusion variants; Neuroendocrine carcinoma; RNA sequencing; EML4-ALK REARRANGEMENT; CARCINOMA; CRIZOTINIB; IMMUNOHISTOCHEMISTRY; RESISTANCE; VARIANTS; TUMOR; IHC;

D O I：

10.1016/j.cllc.2019.05.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E535 / E540

页数：6

共 29 条

[1] Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization [J].

Ali, Siraj M. ;

Hensing, Thomas ;

Schrock, Alexa B. ;

Allen, Justin ;

Sanford, Eric ;

Gowen, Kyle ;

Kulkarni, Atul ;

He, Jie ;

Suh, James H. ;

Lipson, Doron ;

Elvin, Julia A. ;

Yelensky, Roman ;

Chalmers, Zachary ;

Chmielecki, Juliann ;

Peled, Nir ;

Klempner, Samuel J. ;

Firozvi, Kashif ;

Frampton, Garrett M. ;

Molina, Julian R. ;

Menon, Smitha ;

Brahmer, Julie R. ;

MacMahon, Heber ;

Nowak, Jan ;

Ou, Sai-Hong Ignatius ;

Zauderer, Marjorie ;

Ladanyi, Marc ;

Zakowski, Maureen ;

Fischbach, Neil ;

Ross, Jeffrey S. ;

Stephens, Phil J. ;

Miller, Vincent A. ;

Wakelee, Heather ;

Ganesan, Shridar ;

Salgia, Ravi .

ONCOLOGIST, 2016, 21 (06) :762-770

[2] Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) [J].

Barlesi, Fabrice ;

Mazieres, Julien ;

Merlio, Jean-Philippe ;

Debieuvre, Didier ;

Mosser, Jean ;

Lena, Herve ;

Ouafik, L'Houcine ;

Besse, Benjamin ;

Rouquette, Isabelle ;

Westeel, Virginie ;

Escande, Fabienne ;

Monnet, Isabelle ;

Lemoine, Antoinette ;

Veillon, Remi ;

Blons, Helene ;

Audigier-Valette, Clarisse ;

Bringuier, Pierre-Paul ;

Lamy, Regine ;

Beau-Faller, Michele ;

Pujol, Jean-Louis ;

Sabourin, Jean-Christophe ;

Penault-Llorca, Frederique ;

Denis, Marc G. ;

Lantuejoul, Sylvie ;

Morin, Franck ;

Quan Tran ;

Missy, Pascale ;

Langlais, Alexandra ;

Milleron, Bernard ;

Cadranel, Jacques ;

Soria, Jean-Charles ;

Zalcman, Gerard .

LANCET, 2016, 387 (10026) :1415-1426

[3] Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma [J].

Caumont, Charline ;

Veillon, Remi ;

Gros, Audrey ;

Laharanne, Elodie ;

Begueret, Hugues ;

Merlio, Jean-Philippe .

LUNG CANCER, 2016, 92 :15-18

[4] A Case of Atypical Carcinoid Harboring Variant 3a/b EML4-ALK Rearrangement [J].

Fukuizumi, Aya ;

Akagi, Kiwamu ;

Sakai, Hiroshi .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (10) :E104-E106

[5] Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib [J].

Hayashi, Nobuyoshi ;

Fujita, Akihisa ;

Saikai, Toyohiro ;

Takabatake, Hirotugu ;

Sotoshiro, Mie ;

Sekine, Kyuutarou ;

Kawana, Akihiko .

INTERNAL MEDICINE, 2018, 57 (05) :713-716

[6] Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors [J].

Hoton, Delphine ;

Humblet, Yves ;

Libbrecht, Louis .

HISTOPATHOLOGY, 2018, 72 (04) :707-710

[7] Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer [J].

Karlsson, Anna ;

Brunnstrom, Hans ;

Lindquist, Kajsa Ericson ;

Jirstrom, Karin ;

Jonsson, Mats ;

Rosengren, Frida ;

Reutersward, Christel ;

Cirenajwis, Helena ;

Borg, Ake ;

Jonsson, Per ;

Planck, Maria ;

Jonsson, Goran ;

Staaf, Johan .

ONCOTARGET, 2015, 6 (26) :22028-22037

[8] TRK Inhibition: A New Tumor-Agnostic Treatment Strategy [J].

Kummar, Shivaani ;

Lassen, Ulrik N. .

TARGETED ONCOLOGY, 2018, 13 (05) :545-556

[9] Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer [J].

Lin, Jessica J. ;

Zhu, Viola W. ;

Yoda, Satoshi ;

Yeap, Beow Y. ;

Schrock, Alexa B. ;

Dagogo-Jack, Ibiayi ;

Jessop, Nicholas A. ;

Jiang, Ginger Y. ;

Le, Long P. ;

Gowen, Kyle ;

Stephens, Philip J. ;

Ross, Jeffrey S. ;

Ali, Siraj M. ;

Miller, Vincent A. ;

Johnson, Melissa L. ;

Lovly, Christine M. ;

Hata, Aaron N. ;

Gainor, Justin F. ;

Iafrate, Anthony J. ;

Shaw, Alice T. ;

Ou, Sai-Hong Ignatius .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) :1199-+

[10] Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma [J].

Lou, Guangyuan ;

Yu, Xinmin ;

Song, Zhengbo .

CLINICAL LUNG CANCER, 2017, 18 (03) :E197-E201

← 1 2 3 →